141 related articles for article (PubMed ID: 27565322)
1. Silencing of ATPase family AAA domain-containing protein 2 inhibits migration and invasion of colorectal cancer cells.
Hong S; Bi M; Yan Z; Sun D; Ling L; Zhao C
Neoplasma; 2016; 63(6):846-855. PubMed ID: 27565322
[TBL] [Abstract][Full Text] [Related]
2. ATAD2 overexpression is associated with progression and prognosis in colorectal cancer.
Hou M; Huang R; Song Y; Feng D; Jiang Y; Liu M
Jpn J Clin Oncol; 2016 Mar; 46(3):222-7. PubMed ID: 26819280
[TBL] [Abstract][Full Text] [Related]
3. Silencing METTL3 inhibits the proliferation and invasion of osteosarcoma by regulating ATAD2.
Zhou L; Yang C; Zhang N; Zhang X; Zhao T; Yu J
Biomed Pharmacother; 2020 May; 125():109964. PubMed ID: 32044716
[TBL] [Abstract][Full Text] [Related]
4. ATAD2 silencing decreases VEGFA secretion through targeting has-miR-520a to inhibit angiogenesis in colorectal cancer.
Hong S; Chen S; Wang X; Sun D; Yan Z; Tai J; Bi M
Biochem Cell Biol; 2018 Dec; 96(6):761-768. PubMed ID: 29958090
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of ATAD2 indicates Poor Prognosis in Oral Squamous Cell Carcinoma.
Wang XL; Wang S; Wu ZZ; Yang QC; Li H; Xiong HG; Wan SC; Sun ZJ
Int J Med Sci; 2020; 17(11):1598-1609. PubMed ID: 32669963
[TBL] [Abstract][Full Text] [Related]
6. ATAD2 drives colorectal cancer progression by regulating TRIM25 expression via a positive feedback loop with E2F transcriptional factors.
Tong Y; Li J; Peng M; Qian Q; Shi W; Chen Z; Liu B
Biochem Biophys Res Commun; 2022 Feb; 594():146-152. PubMed ID: 35085891
[TBL] [Abstract][Full Text] [Related]
7. Oncogene ATAD2 promotes cell proliferation, invasion and migration in cervical cancer.
Zheng L; Li T; Zhang Y; Guo Y; Yao J; Dou L; Guo K
Oncol Rep; 2015 May; 33(5):2337-44. PubMed ID: 25813398
[TBL] [Abstract][Full Text] [Related]
8. ATAD2 expression increases [18F]Fluorodeoxyglucose uptake value in lung adenocarcinoma via AKT-GLUT1/HK2 pathway.
Sun T; Du B; Diao Y; Li X; Chen S; Li Y
BMB Rep; 2019 Jul; 52(7):457-462. PubMed ID: 31186081
[TBL] [Abstract][Full Text] [Related]
9. ATPase family AAA domain-containing protein 2 (ATAD2): From an epigenetic modulator to cancer therapeutic target.
Fu J; Zhang J; Chen X; Liu Z; Yang X; He Z; Hao Y; Liu B; Yao D
Theranostics; 2023; 13(2):787-809. PubMed ID: 36632213
[TBL] [Abstract][Full Text] [Related]
10. Silence of ATAD2 inhibits proliferation of colorectal carcinoma via the Rb-E2F1 signaling.
Wang JH; Yu TT; Li Y; Hao YP; Han L; Xu KY; Xu P
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):6055-6063. PubMed ID: 32572920
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of microRNA-186 inhibits angiogenesis in retinoblastoma via the Hedgehog signaling pathway by targeting ATAD2.
Wu S; Han M; Zhang C
J Cell Physiol; 2019 Aug; 234(10):19059-19072. PubMed ID: 30993715
[TBL] [Abstract][Full Text] [Related]
12. Suppression of ATAD2 inhibits hepatocellular carcinoma progression through activation of p53- and p38-mediated apoptotic signaling.
Lu WJ; Chua MS; So SK
Oncotarget; 2015 Dec; 6(39):41722-35. PubMed ID: 26497681
[TBL] [Abstract][Full Text] [Related]
13. Emerging oncogene ATAD2: Signaling cascades and therapeutic initiatives.
Nayak A; Dutta M; Roychowdhury A
Life Sci; 2021 Jul; 276():119322. PubMed ID: 33711386
[TBL] [Abstract][Full Text] [Related]
14. HIF1α-dependent upregulation of ATAD2 promotes proliferation and migration of stomach cancer cells in response to hypoxia.
Nayak A; Roy AD; Rout N; Singh SP; Bhattacharyya A; Roychowdhury A
Biochem Biophys Res Commun; 2020 Mar; 523(4):916-923. PubMed ID: 31959473
[TBL] [Abstract][Full Text] [Related]
15. FAM83D knockdown regulates proliferation, migration and invasion of colorectal cancer through inhibiting FBXW7/Notch-1 signalling pathway.
Mu Y; Zou H; Chen B; Fan Y; Luo S
Biomed Pharmacother; 2017 Jun; 90():548-554. PubMed ID: 28407575
[TBL] [Abstract][Full Text] [Related]
16. Pea3 expression promotes the invasive and metastatic potential of colorectal carcinoma.
Mesci A; Taeb S; Huang X; Jairath R; Sivaloganathan D; Liu SK
World J Gastroenterol; 2014 Dec; 20(46):17376-87. PubMed ID: 25516649
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-520f suppresses growth of gastric carcinoma cells by target ATPase family AAA domain-containing protein 2 (ATAD2).
Hong S; Bi M; Chen S; Zhao P; Li B; Sun D; Tai J
Neoplasma; 2016; 63(6):873-879. PubMed ID: 27565325
[TBL] [Abstract][Full Text] [Related]
18. IWR-1 inhibits epithelial-mesenchymal transition of colorectal cancer cells through suppressing Wnt/β-catenin signaling as well as survivin expression.
Lee SC; Kim OH; Lee SK; Kim SJ
Oncotarget; 2015 Sep; 6(29):27146-59. PubMed ID: 26450645
[TBL] [Abstract][Full Text] [Related]
19. Fragment-based design, synthesis and biological evaluation of theophylline derivatives as ATAD2 inhibitors in BT-549 cells.
Yao D; You J; Yang X; Zhang J; Yao X
J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2242601. PubMed ID: 37533352
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of long non-coding RNA-CTD903 inhibits colorectal cancer invasion and migration by repressing Wnt/β-catenin signaling and predicts favorable prognosis.
Yuan Z; Yu X; Ni B; Chen D; Yang Z; Huang J; Wang J; Chen D; Wang L
Int J Oncol; 2016 Jun; 48(6):2675-85. PubMed ID: 27035092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]